The invention concerns nucleic acid molecules derived from novel hepatitis
D virus strains or isolates constituting genotypes different from known
I, II and III genotypes, their fragments, corresponding proteins and
their uses as diagnostic reagents. The invention also concerns a method
for sensitive diagnosis of the hepatitis D virus (or delta hepatitis
virus) and a method for epidemiologic monitoring of HDV-related
infections.
